Skip to content

Effect of propofol on sleep quality of critically ill patients

Effect of propofol on sleep quality of critically ill patients: a randomised placebo controlled cross-over trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN72847182
Enrollment
10
Registered
2009-10-29
Start date
2009-10-20
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Critically ill patients Not Applicable

Interventions

Each patient will be studied on two consecutive nights (from 9:00 pm to 7:00 am). In each patient two nights polysomnography studies will be performed with or without propofol in random order. Propofo

Sponsors

Cretan Critical Care Society (Greece)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Critically ill patients, on mechanical ventilation for at least 48 hours, haemodynamically stable 2.Ventilated on assist mode 3. No respiratory distress 4. Aged between 18 and 85 years, inclusive, either sex

Exclusion criteria

Exclusion criteria: 1. Aged less than 18 and greater than 85 years 2. Severe haemodynamic instability 3. Pregnancy 4. End stage disease 5. Respiratory distress 6. Acute brain injury

Design outcomes

Primary

MeasureTime frame
1. Effect of propofol on sleep quality, measured immediately after each study night 2. Sleep architecture, scored manually by an expert physician not involved in the study. 3. Central apnoeas, arousals and awakenings, defined using standard criteria 4. Total sleep fragmentation, calculated as the sum of arousals and awakenings per hour of sleep

Secondary

MeasureTime frame
Not provided at time of registration

Countries

Greece

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026